Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Leber

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|April 20, 2021
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trialDennis D H Kim, Igor Novitzky-Basso, Taehyung S Kim, et al.
Leukemia & Lymphoma|January 6, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registryRena Buckstein, Lisa Chodirker, Karen W L Yee, et al.
JACC. Advances|May 23, 2025
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationNazanin Aghel, Vincent Wang, Darryl Leong, et al.
American Journal of Hematology|December 21, 2023
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studiesRena Buckstein, Jeannie Callum, Anca Prica, et al.
Cell Reports. Medicine|April 6, 2024
Identification of cells of leukemic stem cell origin with non-canonical regenerative propertiesCameron G Hollands, Allison L Boyd, Xueli Zhao, et al.
Nature|May 30, 2014
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidationHiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Sarit Assouline, et al.
Blood|August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancyCarolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Cell Chemical Biology|April 11, 2017
A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes NeuroprotectionXin Niu, Hetal Brahmbhatt, Philipp Mergenthaler, et al.
Nature Cell Biology|October 17, 2017
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow nicheAllison L Boyd, Jennifer C Reid, Kyle R Salci, et al.
Annals of Hematology|October 5, 2017
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registryBrett L Houston, Jennifer Jayakar, Richard A Wells, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|April 20, 2021
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trialDennis D H Kim, Igor Novitzky-Basso, Taehyung S Kim, et al.
Leukemia & Lymphoma|January 6, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registryRena Buckstein, Lisa Chodirker, Karen W L Yee, et al.
JACC. Advances|May 23, 2025
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationNazanin Aghel, Vincent Wang, Darryl Leong, et al.
American Journal of Hematology|December 21, 2023
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studiesRena Buckstein, Jeannie Callum, Anca Prica, et al.
Cell Reports. Medicine|April 6, 2024
Identification of cells of leukemic stem cell origin with non-canonical regenerative propertiesCameron G Hollands, Allison L Boyd, Xueli Zhao, et al.
Nature|May 30, 2014
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidationHiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Sarit Assouline, et al.
Blood|August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancyCarolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Cell Chemical Biology|April 11, 2017
A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes NeuroprotectionXin Niu, Hetal Brahmbhatt, Philipp Mergenthaler, et al.
Nature Cell Biology|October 17, 2017
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow nicheAllison L Boyd, Jennifer C Reid, Kyle R Salci, et al.
Annals of Hematology|October 5, 2017
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registryBrett L Houston, Jennifer Jayakar, Richard A Wells, et al.
Pageof 13